全球动静脉畸形 (AVM) 市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球动静脉畸形 (AVM) 市场 – 行业趋势和 2030 年预测

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Arteriovenous Malformations Avms Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 2,758.27 Million
Diagram Market Size (Forecast Year)
USD 4,563.64 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Electrical Geodesics
  • Siemens Healthcare
  • Masimo Corporation
  • Esaote
  • Shimadzu Corporation

>全球动静脉畸形 (AVM) 市场,按类型(真性动静脉畸形、隐匿性或隐秘性、海绵状畸形、静脉畸形、血管瘤、硬膜瘘、其他)、分期(第一期(静止期)、第二期(扩张期)、第三期(破坏期)、第四期(失代偿期)、其他)、治疗(诊断、药物治疗、手术、其他)、最终用户(医院、专科诊所、家庭医疗保健、其他)、分销渠道(直接招标、医院药房、零售药房、网上药房、其他)划分 - 行业趋势和预测到 2030 年。

动静脉畸形 (AVM) 市场

动静脉畸形 (AVM) 市场分析和规模

动静脉畸形 (AVM) 非常罕见,在普通人群中发生率不到 1%。男性 AVM 比女性更常见。大多数 AVM 患者不会出现任何问题。然而,近 12% 的 AVM 患者确实会出现一些症状。根据研究,不到 4% 的 AVM 会出现出血,约 1% 的 AVM 患者会直接因 AVM 而死亡。

Data Bridge Market Research 分析称,2022 年全球动静脉畸形 (AVM) 市场规模为 27.5827 亿美元,预计到 2030 年将达到 45.6364 亿美元,预计在 2023 年至 2030 年的预测期内复合年增长率为 6.1%。由于患者对更好的治疗方法的需求不断增长,“药物”在全球动静脉畸形 (AVM) 市场的治疗领域占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外,Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

动静脉畸形 (AVM) 市场范围和细分

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入(百万美元)、销量(单位)和定价(美元)

涵盖的领域

类型(真性动静脉畸形、隐匿性或隐秘性、海绵状畸形、静脉畸形、血管瘤、硬膜瘘、其他)、阶段(I 期(静止期)、II 期(扩张期)、III 期(破坏期)、IV 期(失代偿期)、其他)、治疗(诊断、药物治疗、手术、其他)、最终用户(医院、专科诊所、家庭医疗保健、其他)、分销渠道(直接招标、医院药房、零售药房、网上药房、其他)

覆盖国家

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Electrical Geodesics Inc. (U.S.), Siemens Healthcare (Germany), Masimo Corporation (U.S.), Esaote (Italy), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Philips Healthcare (Netherlands), Pfizer Inc. (U.S.), Eli Lilly and Company (U.S.), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland) and Eisai Co., Ltd (Japan)

Market Opportunities

  • Growing research and development
  • Rising demand for minimally invasive procedures

Market Definition

Arteriovenous malformations (AVMs) are an abnormal tangle of a blood vessel that connects arteries and veins and disrupt the normal blood flow and oxygen circulation. When AVMs occur in any part of the body the surrounding tissues may not get enough oxygen and the affected vein and arteries get weaken and ruptured. If AVMs are in the brain and ruptured, it may cause bleeding in the brain which leads to the connection of haemorrhage, stroke, or brain damage. AVMs can occur anywhere in the body but majorly they are found in the brain and spine.

Global Arteriovenous Malformations (AVMs) Market Dynamics

Drivers

  • Increasing Prevalence of Arteriovenous Malformations

The rising prevalence of arteriovenous malformations is a significant driver for the market. AVMs are relatively rare, but their occurrence is increasing, leading to a growing patient population in need of diagnosis and treatment.

  • Increasing in the Healthcare Expenditure

Rising healthcare expenditure, particularly in developing countries, allows for better access to healthcare facilities, including diagnostics and treatments for AVMs. Increased healthcare spending contributes to the growth of the global arteriovenous malformations (AVMs) market.

Opportunities

  • Growing Research and Development

Increased research activities focused on understanding the pathophysiology of AVMs, developing new treatment modalities, and discovering novel therapeutic targets provide opportunities for innovation. Research collaborations, clinical trials, and investments in R&D can drive market growth by introducing new treatment options.

  • Rising Demand for Minimally Invasive Procedures

Minimally invasive treatment options, such as endovascular embolization and stereotactic radiosurgery, are gaining popularity due to their reduced invasiveness, shorter recovery times, and lower complication rates compared to traditional surgical approaches. The market can capitalize on the growing demand for these less invasive procedures.

Restraints/Challenges

  • Limited Awareness and Diagnosis

A significant restraint for the global arteriovenous malformations (AVMs) market is the lack of awareness and delayed diagnosis of AVMs. Many AVMs are asymptomatic or have non-specific symptoms, leading to under-diagnosis or misdiagnosis. This can result in delayed treatment and hinder market growth.

  • High Cost of Treatment

The treatment of AVMs can be costly, especially for complex cases that require multiple interventions or surgeries. The high cost of treatment can limit access to care, particularly in regions with limited healthcare resources or inadequate insurance coverage. Affordability issues can restrain market growth.

This global arteriovenous malformations (AVMs) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global arteriovenous malformations (AVMs) market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Development

  • In August 2021, Siemens Healthineers has launched its advanced medical imaging solutions, including MRI, CT, and interventional imaging system. They have its presence globally and strives to enhance imaging capabilities for accurate AVM diagnosis and treatment planning for AVMs

Global Arteriovenous Malformations (AVMs) Market Scope

The global arteriovenous malformations (AVMs) market is segmented on the basis of type, stages, treatment, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • True Arteriovenous Malformation
  • Occult or Cryptic
  • Cavernous Malformations
  • Venous Malformation
  • Hemangioma
  • Dural Fistula
  • Others

Stages

  • Stage I (Quiescence)
  • Stage II (Expansion)
  • Stage III (Destruction)
  • Stage IV (Decompensation)
  • Others

Treatment

  • Diagnosis
  • Cerebral Angiography
  • Computerized Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Transcranial Doppler Ultrasound
  • Others
  • Medication
  • Anti-Seizures
  • Pain Relievers
  • Others
  • Surgery
  • Others

End Users

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

Distribution Channel

  • Direct Tender
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Global Arteriovenous Malformations (AVMs) Market Regional Analysis/Insights

对全球动静脉畸形 (AVM) 市场进行了分析,并按国家、类型、阶段、治疗、最终用户和分销渠道提供了市场规模洞察和趋势。

全球动静脉畸形 (AVM) 市场报告涵盖的国家包括美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区

北美在全球动静脉畸形 (AVM) 市场占据主导地位,因为其拥有强大的医疗设施基础、主要市场参与者的强大影响力、卓越的医疗保健基础设施以及用于治疗神经系统疾病的神经药物消费量的增加。   

预计在 2023 年至 2030 年的预测期内,亚太地区将见证全球动静脉畸形 (AVM) 市场的显著增长,原因是政府推动医疗保健的举措增多、人们健康意识的不断增强以及对诊断和治疗程序的先进医疗技术的需求不断增长、人口众多以及对优质医疗服务的需求不断增长。

报告的国家部分还提供了影响单个市场影响因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税的影响和贸易路线。   

医疗保健基础设施增长安装基础和新技术渗透

全球动静脉畸形 (AVM) 市场还为您提供了详细的市场分析,包括每个国家/地区在资本设备医疗保健支出方面的增长情况、全球动静脉畸形 (AVM) 市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管场景的变化及其对全球动静脉畸形 (AVM) 市场的影响。

竞争格局和动静脉畸形 (AVM) 市场份额分析

全球动静脉畸形 (AVM) 市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球动静脉畸形 (AVM) 市场的关注有关。

全球动静脉畸形 (AVM) 市场的一些主要参与者包括:

  • Electrical Geodesics Inc.(美国)
  • 西门子医疗(德国)
  • Masimo 公司 (美国)
  • Esaote(意大利)
  • 岛津制作所(日本)
  • 东芝医疗系统公司(日本)
  • Carestream Health(美国)
  • 飞利浦医疗保健(荷兰)
  • 辉瑞公司 (美国)
  • 礼来公司 (美国)
  • 诺华公司(瑞士)
  • F. Hoffmann-La Roche Ltd(瑞士)
  • 卫材株式会社(日本)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global Arteriovenous Malformations (AVMs) Market, By Type (True Arteriovenous Malformation, Occult or Cryptic, Cavernous Malformations, Venous Malformation, Hemangioma, Dural Fistula, Others), Stages (Stage I (Quiescence), Stage II (Expansion), Stage III (Destruction), Stage IV (Decompensation), Others), Treatment (Diagnosis, Medication, Surgery, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030. .
The Global Arteriovenous Malformations Avms Market size was valued at USD 2758.27 USD Million in 2022.
The Global Arteriovenous Malformations Avms Market is projected to grow at a CAGR of 6.1% during the forecast period of 2023 to 2030.
The major players operating in the market include Electrical Geodesics , Siemens Healthcare, Masimo Corporation, Esaote, Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Philips Healthcare, Pfizer , Eli Lilly and Company, Novartis AG, F. Hoffmann La Roche Ltd, Eisai Co.,.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.